United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. DHR
2. NOW
3. USO
4. NVDA
5. SPY
6. AMD
7. SMCI
8. GOOGL
9. TSLA
10. GM

Go back to United Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusion
United Therapeutics Corp (NASDAQ: UTHR) Delayed: 527.07 -8.76 (1.63%)
Previous Close $535.83    52 Week High $164.04 
Open $535.83    52 Week Low $97.52 
Day High $541.25    P/E 96.36 
Day Low $521.73    EPS $5.47 
Volume 469,812